Our primary business focus is on complex, regulated drug delivery devices and connected health…
Phillips-Medisize is an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical,…
Author
Digital era of drug development
The Indian pharma sector needs more actionable and optimised drug development and delivery models driven by data and new-age…
DCGI delivers BV Patel Memorial Lecture at IPC 2018
Urges that building trust in India's medicines and positive image of regulators is the need of the hour
Industry stakeholders discuss on opportunities and challenges in biosimilars at IPC 2018
Hope that in the coming years India will contribute significantly to the growth of the biosimilars sector globally
Trends in medical devices in changing regulatory environment discussed at IPC 2018
The session addresses aspects such as data security, affordability of medical devices, impact on healthcare outcomes and…
Protinex joins hands with InBody to establish protein relevance for better muscle health
71 per cent Indians have poor muscle health, 68 per cent have low protein levels – says InBody study in association with IPSOS…
Flying it for pharma
The air cargo industry needs to up its game by ensuring reliability and safety across the supply chain to leverage the growth…
Delhi hosts third edition of Healthcare Senate
Leaders and game changers in India’s private healthcare sector came together at the event organised by Express Healthcare and The…
The case of Apotex vs Cadila
In a case of Apotex vs Cadila, the former shares details of how the court refused to grant anti-suit injunction to Cadila and…
Alembic Pharma gets USFDA approval for Bupropion Hydrochloride tablets
The drug approval is for strengths of 75 mg and 100 mg and is used to treat major depressive disorder